Literature DB >> 31209903

Deletion of the creatine transporter gene in neonatal, but not adult, mice leads to cognitive deficits.

Kenea C Udobi1,2, Nicholas Delcimmuto1,2, Amanda N Kokenge1,2, Zuhair I Abdulla1,2, Marla K Perna1,2, Matthew R Skelton1,2.   

Abstract

Creatine (Cr) is a guanidino compound that provides readily available phosphate pools for the regeneration of spent adenosine triphosphate (ATP). The lack of brain Cr causes moderate to severe intellectual disability, language impairment, and epilepsy. The most prevalent cause of Cr deficiency are mutations in the X-linked SLC6A8 (Creatine transporter; CrT) gene, known as CrT deficiency (CTD). One of the most critical areas that need to be addressed is whether Cr is necessary for brain development. To address this concern, the Slc6a8 gene was knocked out in either neonatal (postnatal day (P)5) or adult (P60) mice using a tamoxifen-inducible Cre recombinase driven by the human ubiquitin C (UBC) promoter. Mice were tested in the Morris water maze, novel, object recognition, and conditioned fear 60 days after Slc6a8 deletion. In addition, overnight locomotor activity was analyzed. Mice that had the gene deleted on P5 showed deficits in the Morris water maze and novel object recognition, while there were no deficits in P60 knockout mice. Interestingly, the P5 knockout mice showed hyperactivity during the dark phase; however, when examining control mice, the effect was due to the administration of tamoxifen from P5 to 10. Taken together, the results of this study show that Cr is necessary during periods of brain development involved in spatial and object learning. This study also highlights the continued importance of using proper control groups for behavioral testing.
© 2019 SSIEM.

Entities:  

Year:  2019        PMID: 31209903      PMCID: PMC6739135          DOI: 10.1002/jimd.12137

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  37 in total

1.  Reversed-phase HPLC with UV detection for the determination of N-acetylaspartate and creatine.

Authors:  Mattias Tranberg; Malin H Stridh; Barbro Jilderos; Stephen G Weber; Mats Sandberg
Journal:  Anal Biochem       Date:  2005-03-30       Impact factor: 3.365

2.  A CamKIIalpha iCre BAC allows brain-specific gene inactivation.

Authors:  E Casanova; S Fehsenfeld; T Mantamadiotis; T Lemberger; E Greiner; A F Stewart; G Schütz
Journal:  Genesis       Date:  2001-09       Impact factor: 2.487

3.  Refining the critical period for methamphetamine-induced spatial deficits in the Morris water maze.

Authors:  Michael T Williams; Mary S Moran; Charles V Vorhees
Journal:  Psychopharmacology (Berl)       Date:  2003-04-09       Impact factor: 4.530

4.  Impaired recognition memory in rats after damage to the hippocampus.

Authors:  R E Clark; S M Zola; L R Squire
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

5.  Selective and long-term learning impairment following neonatal hypoxic-ischemic brain insult in rats.

Authors:  T Ikeda; K Mishima; T Yoshikawa; K Iwasaki; M Fujiwara; Y X Xia; T Ikenoue
Journal:  Behav Brain Res       Date:  2001-01-08       Impact factor: 3.332

6.  The clinical syndrome of creatine transporter deficiency.

Authors:  Ton J deGrauw; Kim M Cecil; Anna W Byars; Gajja S Salomons; William S Ball; Cornelis Jakobs
Journal:  Mol Cell Biochem       Date:  2003-02       Impact factor: 3.396

Review 7.  Creatine deficiency syndromes.

Authors:  Andreas Schulze
Journal:  Mol Cell Biochem       Date:  2003-02       Impact factor: 3.396

8.  Irreversible brain creatine deficiency with elevated serum and urine creatine: a creatine transporter defect?

Authors:  K M Cecil; G S Salomons; W S Ball; B Wong; G Chuck; N M Verhoeven; C Jakobs; T J DeGrauw
Journal:  Ann Neurol       Date:  2001-03       Impact factor: 10.422

Review 9.  Creatine and creatinine metabolism.

Authors:  M Wyss; R Kaddurah-Daouk
Journal:  Physiol Rev       Date:  2000-07       Impact factor: 37.312

10.  Incidence of brain creatine transporter deficiency in males with developmental delay referred for brain magnetic resonance imaging.

Authors:  Amy Newmeyer; Kim M Cecil; Mark Schapiro; Joseph F Clark; Ton J Degrauw
Journal:  J Dev Behav Pediatr       Date:  2005-08       Impact factor: 2.225

View more
  6 in total

Review 1.  The Role of Preclinical Models in Creatine Transporter Deficiency: Neurobiological Mechanisms, Biomarkers and Therapeutic Development.

Authors:  Elsa Ghirardini; Francesco Calugi; Giulia Sagona; Federica Di Vetta; Martina Palma; Roberta Battini; Giovanni Cioni; Tommaso Pizzorusso; Laura Baroncelli
Journal:  Genes (Basel)       Date:  2021-07-24       Impact factor: 4.096

2.  Deletion of the Creatine Transporter (Slc6a8) in Dopaminergic Neurons Leads to Hyperactivity in Mice.

Authors:  Zuhair I Abdulla; Bahar Pahlevani; Kerstin H Lundgren; Jordan L Pennington; Kenea C Udobi; Kim B Seroogy; Matthew R Skelton
Journal:  J Mol Neurosci       Date:  2019-09-13       Impact factor: 3.444

3.  Maternal Creatine Supplementation Positively Affects Male Rat Hippocampal Synaptic Plasticity in Adult Offspring.

Authors:  Stefano Sartini; Davide Lattanzi; Michael Di Palma; David Savelli; Silvia Eusebi; Piero Sestili; Riccardo Cuppini; Patrizia Ambrogini
Journal:  Nutrients       Date:  2019-08-27       Impact factor: 5.717

4.  A new rat model of creatine transporter deficiency reveals behavioral disorder and altered brain metabolism.

Authors:  Lara Duran-Trio; Gabriella Fernandes-Pires; Dunja Simicic; Jocelyn Grosse; Clothilde Roux-Petronelli; Stephen J Bruce; Pierre-Alain Binz; Carmen Sandi; Cristina Cudalbu; Olivier Braissant
Journal:  Sci Rep       Date:  2021-01-15       Impact factor: 4.379

5.  Creatine transporter-deficient rat model shows motor dysfunction, cerebellar alterations, and muscle creatine deficiency without muscle atrophy.

Authors:  Lara Duran-Trio; Gabriella Fernandes-Pires; Jocelyn Grosse; Ines Soro-Arnaiz; Clothilde Roux-Petronelli; Pierre-Alain Binz; Katrien De Bock; Cristina Cudalbu; Carmen Sandi; Olivier Braissant
Journal:  J Inherit Metab Dis       Date:  2021-12-26       Impact factor: 4.750

Review 6.  The Creatine Transporter Unfolded: A Knotty Premise in the Cerebral Creatine Deficiency Syndrome.

Authors:  Clemens V Farr; Ali El-Kasaby; Michael Freissmuth; Sonja Sucic
Journal:  Front Synaptic Neurosci       Date:  2020-10-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.